✦ LIBER ✦

Optimizing ribavirin dosage: A new challenge to improve treatment efficacy in genotype 1 hepatitis C patients

✍ Scribed by V. Loustaud-Ratti; F. Stanke-Labesque; P. Marquet; M.-C. Gagnieu; M. Maynard; G. Babany; C. Trépo

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Optimizing Ribavirin Exposure by Therape

✍ Stickel, Felix; Worni, Mathias; Pache, Isabelle; Moradpour, Darius; Helbling, Be 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 141 KB

Impact of Ribavirin Dose Reductions in H

✍ Reddy, K. Rajender; Shiffman, Mitchell L.; Morgan, Timothy R.; Zeuzem, Stefan; H 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 131 KB

Sofosbuvir and Ribavirin for Hepatitis C

✍ Osinusi, Anuoluwapo; Meissner, Eric G.; Lee, Yu-Jin; Bon, Dimitra; Heytens, Laur 📂 Article 📅 2013 🏛 American Medical Association 🌐 English ⚖ 294 KB

Meta-analysis: amantadine may lower the

✍ Jian Chen; Jian Shi; Wei-Fen Xie; Xin Zeng; Yong Lin 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 496 KB

The Treatment Efficacy of Pegylated Inte

✍ Huang, Ching-I; Huang, Chung-Feng; Huang, Jee-Fu; Dai, Chia-Yen; Yeh, Ming-Lun; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Effect of Ribavirin in Genotype 1 Patien

✍ Jean–Pierre Bronowicki; Denis Ouzan; Tarik Asselah; Hervé Desmorat; Jean–Pierre 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 378 KB